PROTHENA CORPORATION PUBLIC LIMITED COMPANY Earnings Per Share (Diluted)
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Earnings Per Share (Diluted) of -$0.36 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for the quarter ending 2026-06-30 was -$0.36.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for the quarter ending 2026-03-31 was $0.60.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for the quarter ending 2025-12-31 was -$0.40.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for the quarter ending 2025-09-30 was -$0.68.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for fiscal 2025 was -$4.53.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for fiscal 2024 was -$2.27.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for fiscal 2023 was -$2.76.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY earnings per share, diluted for fiscal 2022 was -$2.47, a 278.99% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.36 10-Q · filed 2026-08-06 | $0.26 10-Q · filed 2026-08-06 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | $0.60 10-Q · filed 2026-05-07 | $0.21 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.80 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$3.42 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.53 10-K · filed 2026-02-27 |
| 2025-09-30 | -$0.68 10-Q · filed 2025-11-06 | -$3.02 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.13 10-Q · filed 2025-11-06 | -$5.21 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$2.34 10-Q · filed 2026-08-06 | -$3.45 10-Q · filed 2026-08-06 | -$4.53 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$5.63 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$1.12 10-Q · filed 2026-05-07 | -$2.20 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.29 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.04 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$2.17 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$2.27 10-K · filed 2026-02-27 |
| 2024-09-30 | -$1.10 10-Q · filed 2025-11-06 | $0.14 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.20 10-Q · filed 2025-11-06 | -$2.44 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-06-30 | $1.22 10-Q · filed 2025-08-04 | -$0.10 10-Q · filed 2025-08-04 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-03-31 | -$1.34 10-Q · filed 2025-05-08 | -$2.60 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$3.16 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2023-12-31 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$1.82 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$2.76 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.38 10-Q · filed 2024-11-12 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.50 10-Q · filed 2024-11-12 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-06-30 | -$1.03 10-Q · filed 2024-08-08 | -$1.92 10-Q · filed 2024-08-08 | -$1.85 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.80 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-03-31 | -$0.89 10-Q · filed 2024-05-08 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.74 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.61 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2022-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.69 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.47 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.97 10-Q · filed 2023-11-02 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$2.63 10-Q · filed 2023-11-02 | -$3.25 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-06-30 | -$0.88 10-Q · filed 2023-08-03 | -$1.66 10-Q · filed 2023-08-03 | -$2.28 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-03-31 | -$0.78 10-Q · filed 2023-05-04 | -$1.40 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.79 derived: net income ÷ weighted average shares · filed 2024-02-22 | $1.36 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2021-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-02-22 | $1.47 derived: net income ÷ weighted average shares · filed 2024-02-22 | $2.06 derived: net income ÷ weighted average shares · filed 2024-02-22 | $1.38 10-K · filed 2024-02-22 |
| 2021-09-30 | $2.13 10-Q · filed 2022-11-03 | $2.78 derived: net income ÷ weighted average shares · filed 2022-11-03 | $2.12 10-Q · filed 2022-11-03 | $1.55 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2021-06-30 | $0.58 10-Q · filed 2022-08-08 | -$0.21 10-Q · filed 2022-08-08 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2021-03-31 | -$0.91 10-Q · filed 2022-05-05 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.45 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$3.11 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2020-12-31 | -$0.77 10-K · filed 2021-02-26 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.19 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.78 10-K · filed 2023-02-28 |
| 2020-09-30 | -$0.77 10-Q · filed 2021-11-04 | -$1.42 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.02 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$0.66 10-Q · filed 2021-08-05 | -$1.25 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$0.59 10-K · filed 2021-02-26 | |||
| 2019-12-31 | -$0.54 10-K · filed 2021-02-26 | -$1.95 10-K · filed 2022-02-25 | ||
| 2019-09-30 | -$0.49 10-K · filed 2021-02-26 | |||
| 2019-06-30 | -$0.40 10-K · filed 2021-02-26 | |||
| 2019-03-31 | -$0.52 10-K · filed 2021-02-26 | |||
| 2018-12-31 | -$0.56 10-K · filed 2020-03-03 | |||
| 2018-09-30 | -$0.62 10-K · filed 2020-03-03 | |||
| 2018-06-30 | -$1.50 10-K · filed 2020-03-03 | |||
| 2018-03-31 | -$1.26 10-K · filed 2020-03-03 | |||
| 2017-12-31 | -$1.24 10-K · filed 2019-03-15 | |||
| 2017-09-30 | -$1.37 10-K · filed 2019-03-15 | |||
| 2017-06-30 | -$0.46 10-K · filed 2019-03-15 | |||
| 2017-03-31 | -$0.99 10-K · filed 2019-03-15 | |||
| 2016-12-31 | -$1.41 10-K · filed 2018-02-26 | |||
| 2016-09-30 | -$1.26 10-K · filed 2018-02-26 | |||
| 2016-06-30 | -$1.18 10-K · filed 2018-02-26 | |||
| 2016-03-31 | -$0.81 10-K · filed 2018-02-26 | |||
| 2015-12-31 | -$0.76 10-K · filed 2017-02-27 | |||
| 2015-09-30 | -$0.73 10-K · filed 2017-02-27 | -$1.33 derived: net income ÷ weighted average shares · filed 2017-02-27 | -$1.89 10-Q · filed 2015-11-02 | |
| 2015-06-30 | -$0.59 10-K · filed 2017-02-27 | -$1.15 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | -$0.55 10-K · filed 2017-02-27 | |||
| 2014-12-31 | -$0.48 10-K · filed 2016-02-25 | |||
| 2014-09-30 | -$0.48 10-K · filed 2016-02-25 | -$0.47 derived: net income ÷ weighted average shares · filed 2016-02-25 | $0.24 10-Q · filed 2015-11-02 | |
| 2014-06-30 | $0.06 10-K · filed 2016-02-25 | $0.83 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | $0.78 10-K · filed 2016-02-25 | |||
| 2013-09-30 | -$0.55 10-Q · filed 2014-11-04 | -$1.19 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$1.69 10-Q · filed 2014-11-04 | |
| 2013-06-30 | -$0.64 10-Q · filed 2014-08-05 | -$1.15 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | -$0.51 10-Q · filed 2014-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |